Loading...
The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
OBJECTIVES: Both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and metformin (MET) have markedly antiobesity effects in overweight/obese polycystic ovary syndrome (PCOS) patients. However, there was no literature to compare the antiobesity effects of these two medicines. Therefore, a systemat...
Na minha lista:
| Udgivet i: | Int J Endocrinol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910049/ https://ncbi.nlm.nih.gov/pubmed/33679973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6616693 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|